[go: up one dir, main page]

ATE377022T1 - Isolierte decapeptide, die an hla moleküle binden,sowie deren verwendung - Google Patents

Isolierte decapeptide, die an hla moleküle binden,sowie deren verwendung

Info

Publication number
ATE377022T1
ATE377022T1 AT98930433T AT98930433T ATE377022T1 AT E377022 T1 ATE377022 T1 AT E377022T1 AT 98930433 T AT98930433 T AT 98930433T AT 98930433 T AT98930433 T AT 98930433T AT E377022 T1 ATE377022 T1 AT E377022T1
Authority
AT
Austria
Prior art keywords
decapeptides
bind
isolated
hla molecules
hla
Prior art date
Application number
AT98930433T
Other languages
English (en)
Inventor
Danila Valmori
Jean-Charles Cerottini
Pedro Romero
Original Assignee
Ludwig Inst Cancer Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/880,963 external-priority patent/US6025470A/en
Application filed by Ludwig Inst Cancer Res filed Critical Ludwig Inst Cancer Res
Application granted granted Critical
Publication of ATE377022T1 publication Critical patent/ATE377022T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
AT98930433T 1997-06-23 1998-06-18 Isolierte decapeptide, die an hla moleküle binden,sowie deren verwendung ATE377022T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/880,963 US6025470A (en) 1997-06-23 1997-06-23 Isolated nona- and decapeptides which bind to HLA molecules, and the use thereof
US09/061,388 US6277956B1 (en) 1997-06-23 1998-04-16 Isolated nona- and decapeptides which bind to HLA molecules, and the use thereof

Publications (1)

Publication Number Publication Date
ATE377022T1 true ATE377022T1 (de) 2007-11-15

Family

ID=26741014

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98930433T ATE377022T1 (de) 1997-06-23 1998-06-18 Isolierte decapeptide, die an hla moleküle binden,sowie deren verwendung

Country Status (9)

Country Link
US (3) US6326200B1 (de)
EP (1) EP1012173B1 (de)
CN (1) CN1313481C (de)
AT (1) ATE377022T1 (de)
AU (1) AU732468B2 (de)
CA (1) CA2295321C (de)
HK (1) HK1028615A1 (de)
NZ (1) NZ501752A (de)
WO (1) WO1998058951A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE377022T1 (de) * 1997-06-23 2007-11-15 Ludwig Inst Cancer Res Isolierte decapeptide, die an hla moleküle binden,sowie deren verwendung
WO2001016320A1 (en) * 1999-08-30 2001-03-08 Ludwig Institute For Cancer Research Isolated nona and decapeptides which bind to hla molecules, and the use thereof
ATE391726T1 (de) 1999-10-22 2008-04-15 Sanofi Pasteur Ltd Modifiziertes gp100 und dessen verwendung
US20020164654A1 (en) * 2000-01-20 2002-11-07 Rosalie Luiten MAGE antigenic peptides which bind HLA-B35 and HLA-B44
FR2806727A1 (fr) * 2000-03-23 2001-09-28 Pf Medicament Molecule d'interet pharmaceutique comprotant en son extremite n-terminale un acide glutamique ou une glutamine sous forme de sel d'addition d'acide fort physiologiquement acceptable
WO2003024480A2 (en) * 2001-09-14 2003-03-27 Cytos Biotechnology Ag In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
ES2335979T3 (es) * 2001-09-14 2010-04-07 Cytos Biotechnology Ag Empaquetamiento de cpg inmunoestimuladores en particulas similares a virus: metodo de preparacion y su uso.
US20040005338A1 (en) * 2002-06-20 2004-01-08 Cytos Biotechnology Ag Packaged virus-like particles for use as adjuvants: method of preparation and use
WO2004029071A2 (en) 2002-09-27 2004-04-08 Ludwig Institute For Cancer Research Mage-c2 antigenic peptides and uses thereof
US20060210588A1 (en) * 2003-03-26 2006-09-21 Cytos Biotechnology Ag Hiv-peptide-carrier-conjugates
US7537767B2 (en) * 2003-03-26 2009-05-26 Cytis Biotechnology Ag Melan-A- carrier conjugates
RU2351362C2 (ru) * 2003-03-26 2009-04-10 Цитос Байотекнолоджи Аг КОНЪЮГАТЫ ПЕПТИДА Melan-A, АНАЛОГА ВИРУСОПОДОБНОЙ ЧАСТИЦЫ
CA2619443C (en) * 2005-08-09 2014-07-08 Kumamoto University Glypican-3 (gpc3)-derived tumor rejection antigenic peptides useful for hla-a2-positive patients and pharmaceutical comprising the same
NZ569741A (en) * 2005-12-14 2012-02-24 Cytos Biotechnology Ag Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
KR101552227B1 (ko) 2006-06-12 2015-09-10 사이토스 바이오테크놀로지 아게 올리고뉴클레오티드를 ｒｎａ 박테리오파지의 바이러스-유사 입자로 패키징하는 방법
CN110191893B (zh) * 2016-11-22 2023-03-21 武汉华大吉诺因生物科技有限公司 多肽及其应用
CN109923121B (zh) * 2016-11-22 2022-12-23 武汉华大吉诺因生物科技有限公司 多肽及其应用
WO2018098715A1 (zh) * 2016-11-30 2018-06-07 深圳华大基因研究院 多肽及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5662907A (en) * 1992-08-07 1997-09-02 Cytel Corporation Induction of anti-tumor cytotoxic T lymphocytes in humans using synthetic peptide epitopes
US5487974A (en) * 1992-12-22 1996-01-30 Ludwig Institute For Cancer-Research Method for detecting complexes containing human leukocyte antigen A2 (HLA-A2) molecules and a tyrosinase drived peptide on abnormal cells
US5554506A (en) 1994-03-24 1996-09-10 Ludwig Institute For Cancer Research Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof
US5851523A (en) * 1994-03-24 1998-12-22 Ludwig Institute For Cancer Research. Isolated, peptides derived from MAGE tumor rejection antigen precursors which complex with HLA-A2 molecules and uses thereof
US5554724A (en) 1994-03-24 1996-09-10 University Of Leiden Isolated tumor rejection antigen precursor MAGE-2 derived peptides, and uses thereof
WO1995029193A2 (en) * 1994-04-22 1995-11-02 The Government Of The United States Of America Represented By The Secretary, Department Of Health And Human Services Melanoma antigens
US5874560A (en) * 1994-04-22 1999-02-23 The United States Of America As Represented By The Department Of Health And Human Services Melanoma antigens and their use in diagnostic and therapeutic methods
PT900380E (pt) * 1996-04-26 2003-12-31 Univ Leiden Metodos para seleccionar e produzir epitopos peptidicos de celulas t e vacinas que incorporam os referidos epitopos seleccionados
ZA975858B (en) * 1996-07-11 1998-09-01 Akzo Nobel Nv Melanoma associated peptide analogues and vaccines against melanoma
US6025470A (en) * 1997-06-23 2000-02-15 Ludwig Institute For Cancer Research Isolated nona- and decapeptides which bind to HLA molecules, and the use thereof
ATE377022T1 (de) * 1997-06-23 2007-11-15 Ludwig Inst Cancer Res Isolierte decapeptide, die an hla moleküle binden,sowie deren verwendung

Also Published As

Publication number Publication date
CN1313481C (zh) 2007-05-02
US7713714B2 (en) 2010-05-11
EP1012173B1 (de) 2007-10-31
EP1012173A4 (de) 2000-07-05
CN1261374A (zh) 2000-07-26
US6326200B1 (en) 2001-12-04
AU7982798A (en) 1999-01-04
EP1012173A1 (de) 2000-06-28
US20040152193A1 (en) 2004-08-05
WO1998058951A1 (en) 1998-12-30
NZ501752A (en) 2000-12-22
CA2295321A1 (en) 1998-12-30
AU732468B2 (en) 2001-04-26
US20030082804A1 (en) 2003-05-01
US7344879B2 (en) 2008-03-18
CA2295321C (en) 2008-01-29
HK1028615A1 (en) 2001-02-23

Similar Documents

Publication Publication Date Title
ATE377022T1 (de) Isolierte decapeptide, die an hla moleküle binden,sowie deren verwendung
AR004357A1 (es) Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol, y procedimiento de preparacion para dichos compuestos.
ATE318845T1 (de) Therapeutische multispezifische verbindungen, die antikörper gegen den fcalpha-rezeptor enthalten
AU694055B2 (en) Method of using dynamic database to improve telephone number portability
MX9703063A (es) Compuestos de ester y acido boronico, su sintesis y usos.
NO975387D0 (no) Fremgangsmåte for fremstilling av 3-haloalkyl-1H-pyrazoler
EA199700170A1 (ru) Способ получения некоторых азациклогексапетидов
TR199701574T2 (xx) �midazol bile�imleri
BR9602786A (pt) Método para produzir oxigênio e gerar potência
AU6973498A (en) Sustained-release alginate gels
HN1996000017A (es) Isotiazolonas
TR199802676A2 (xx) T�m�rlerin, t�m�rle ilgili hastal�klar�n ve ka�eksinin tedavisi ve �nlenmesi i�in y�ntem.
ES2161279T3 (es) Nucleosidos y nucleotidos que contienen racimos de boro.
DK0711140T3 (da) Antimykotisk opløsning til negle
NO975557L (no) Immortalisering og dissimortalisering av celler
DE69736832D1 (de) Passiv verabreichter antikörper, der die futterausnutzung erhöht
DK1025083T3 (da) Fremgangsmåde til stereoselektiv syntese af prostacyclin-derivater
DE69838646D1 (de) Isolierte decapeptide, die an hla moleküle binden, sowie deren verwendung
ATE432978T1 (de) T-zellaktivierung
BG104291A (en) 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use
DE60007120D1 (de) Isophosphoramide-senfgasanalogen und deren verwendung
DE58906338D1 (de) Kombination von Angiotensin-Converting-Enzyme-Hemmern mit Kaliumkanal-Modulatoren sowie deren Verwendung in Arzneimitteln.
DE69632407D1 (de) Antikörper gegen l-selectin zur vorbeugung von multiplem organversagen und akuter organschädigung
AU5485398A (en) Method for increasing the efficiency of photoelectro-chemical cells, and photoelectro-chemical cells realized according to said method
MX9603087A (es) Procedimiento para la obtencion de aminocarboniltriazolinonas substituidas.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties